Suppression of experimental crescentic glomerulonephritis by peroxisome proliferator-activated receptor (PPAR) γ activators
Suppression of experimental crescentic glomerulonephritis by peroxisome proliferator-activated receptor (PPAR) γ activators
批准号:
13671105
负责人:
HARAGUCHI Kazutaka
金额:
$1.79万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002
中文摘要
点击翻译按钮获取中文摘要
英文摘要
It has been recently reported that peroxisome proliferator-activated receptor (PPAR) γ exhibits anti-inflammatory effects. A couple of reports suggests effects of PPAR γon kidney cells, but precise knowledge are limited.First, we examined the effects of PPARg activators on the apoptosis of clonal kidney cells (LLC-PK1), RT-PCR revealed the expression of PPARg in LLC-PK1 cells. The ligands for PPARg such as troglitazone, BRL49653 and 15-deoxy-delta-12,14-prostaglandin J2 inhibited serum-deprivation-induced apoptosis of the cells. PPARa activators did not mimic the effect of troglitazone. Antiapoptotic effects of troglitazone were partially blocked by a phosphatidyl-inositol-3 kinase (PI3K) inhibitor, wortmannin, but not by other kinase inhibitors. Further, we showed that troglitazone increased the expression of c-myc which was reported to cause apoptosis in the absence of serum in other systems. However, the expression of bcl-2 was not affected. These results suggest that the activation … More of PPARg has an inhibitory effect on the apoptosis induced by serum deprivation through the PI3K pathway in LLC-PK1 cells.Secondary, crescentic glomerulonephritis was induced by the injection of rabbit anti-rat glomerular basement membrane antibody in WKY rats. Administration of troglitazone suppressed urinary protein excretion and crescent formation as indicated by crescent scores. Pioglitazone mimicked the effect of troglitazone, but PPAR α-activators did not. Immunohistology revealed that troglitazone and pioglitazone inhibited the infiltration of ED-1-positive monocyte/macrophages and CD8-positive cells into glomeruli. In the present study, we demonstrated that PPAR γ activators exert antinephritic effects by suppressing the recruitment of inflammatory cells via PPARg-dependent mechanism.In conclusion, in kidney cells, PPAR γ-activators inhibits apoptosis of cultured kidney cells in vitro and suppresses experimental glomerulonephritis in rats, PPARγ-dependent mechanism may have a important role in kidney cells. Less
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Haraguchi Kazutaka: "Suppression of experimental crescentic glomerulonephritis by peroxisome proliferator-activated receptor (PPAR) γ activators"Clin Exp Nephrol. 7. 27-32 (2003)
Haraguchi Kazutaka:“通过过氧化物酶体增殖物激活受体(PPAR)γ激活剂抑制实验性新月体肾小球肾炎”Clin Exp Nephrol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Haraguchi Kazutaka: "Activation of Peroxisome proliferator-activated receptor-g inhibits apoptosis induced by serum deprivation in LLC-PK1 Cells"Exp Nephrol. 10. 393-401 (2002)
Haraguchi Kazutaka:“过氧化物酶体增殖物激活受体-g 的激活抑制 LLC-PK1 细胞中血清剥夺诱导的细胞凋亡”Exp Nephrol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Haraguchi Kazutaka: "Suppression of experimental crescentic glomerulonephritis by peroxisome proliferator-activated receptor (PPAR)γ activators"Clin Exp Nephrol. 7. 27-32 (2003)
Haraguchi Kazutaka:“通过过氧化物酶体增殖物激活受体(PPAR)γ激活剂抑制实验性新月体肾小球肾炎”Clin Exp Nephrol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Haraguchi Kazutaka: "Suppression of experimental crescentic glomerulonephritis by peroxisome probiferator-astivated receptor (PPAR)γ activators"Clin Exp Nephrol. 7. 27-32 (2003)
Haraguchi Kazutaka:“过氧化物酶体激活受体(PPAR)γ激活剂抑制实验性新月体肾小球肾炎”Clin Exp Nephrol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Haraguchi Kazutaka: "Activation of peroxisome proliferator-activated receptor γ inhibits apoptosis induced by serum deprivation in LLC-PK1 cells"Exp Nephrol. 10. 393-401 (2002)
Haraguchi Kazutaka:“过氧化物酶体增殖物激活受体 γ 的激活抑制 LLC-PK1 细胞中血清剥夺诱导的细胞凋亡”Exp Nephrol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 7 条
Molecular Mechanisms of Expression of TSHR and Graves' Ophthaolmopathy
-
批准号:10671032
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.11万
-
财政年份:1998
-
负责人:HARAGUCHI Kazutaka
-
依托单位:
Study on the Pathogenesis of Graves' Ophthalmopathy using 3T3-L1 Cells Which Express Thyrotropin Receptor
-
批准号:08671143
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.47万
-
财政年份:1996
-
负责人:HARAGUCHI Kazutaka
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
-
批准号:31970691
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:张胜萍
-
依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
-
批准号:31900527
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:孙磊
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
姜黄素与TRAIL的协同抗肿瘤机制研究
-
批准号:31101223
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2011
-
负责人:曹林
-
依托单位:
转凝蛋白通过线粒体凋亡途径致足细胞凋亡的机制研究
-
批准号:81100502
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2011
-
负责人:管娜
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位: